Table 1 Positive denotes patients which are ADE positive, whereas Negative corresponds to patients that are ADE negative
Adverse drug event | Positive | Negative |
|---|---|---|
D61.1: Aplastic anaemia | 593 | 105 |
Average age | 50.3 | 55.6 |
Gender distribution (% female) | 42.7 | 49.5 |
E27.3 Adrenocortical insufficiency | 70 | 259 |
Average age | 61.8 | 56 |
Gender distribution (% female) | 58.6 | 58.6 |
G62.0 Polyneuropathy | 96 | 783 |
Average age | 59.8 | 72.7 |
Gender distribution (% female) | 47.9 | 40.1 |
I95.2 Hypotension | 115 | 1287 |
Average age | 79.3 | 74.7 |
Gender distribution (% female) | 40.9 | 49.6 |
L27.0 Generalized skin eruption | 182 | 468 |
Average age | 60.1 | 48.7 |
Gender distribution (% female) | 55.5 | 48.4 |
L27.1 Localized skin eruption | 151 | 498 |
Average age | 59.8 | 55.9 |
Gender distribution (% female) | 50.3 | 54.5 |
M80.4 Osteoporosis | 52 | 1170 |
Average age | 65.8 | 70.9 |
Gender distribution (% female) | 71.15 | 81 |
O35.5 Damage to fetus by drugs | 146 | 260 |
Average age | 38.5 | 38.9 |
Gender distribution (% female) | 100 | 100 |
T78.2 Anaphylactic shock | 131 | 856 |
Average age | 50.9 | 45.46 |
Gender distribution (% female) | 50.4 | 60.7 |
T78.3 Angioneurotic oedema | 283 | 720 |
Average age | 56.4 | 42.35 |
Gender distribution (% female) | 59 | 59.9 |
T78.4 Allergy | 574 | 415 |
Average age | 41.2 | 52.5 |
Gender distribution (% female) | 65.2 | 51.2 |
T80.1 Vascular complications | 66 | 609 |
Average age | 66.2 | 63.2 |
Gender distribution (% female) | 48.5 | 64.7 |
T80.8 Infusion complications | 538 | 138 |
Average age | 64.3 | 60.4 |
Gender distribution (% female) | 65.8 | 52.2 |
T88.6 Anaphylactic shock | 89 | 1506 |
Average age | 56.9 | 58.5 |
Gender distribution (% female) | 51.7 | 57.6 |
T88.7 Unspecified adverse effect | 1047 | 550 |
Average age | 60.9 | 53.6 |
Gender distribution (% female) | 60.2 | 51.3 |